Alex Adams leads Cambium Analytica with passion for science-driven innovation, entrepreneurship, and building bridges between early-stage research and commercial success. In his role as CEO, he has spearheaded growth and differentiation in analytical services, product development, and contract research within natural products sectors such as natural foods, dietary supplements, and botanicals

In October 2025, Cambium Analytica officially joined NSF, becoming Cambium Analytica, an NSF company.  This milestone merges Cambium’s agility and scientific depth with NSF’s global reputation in safety, standards, and compliance. Together, the combined organization now offers seamless, end-to-end service from concept through regulatory readiness and market launch.

Alex has passion and experience in translating complex scientific challenges into real-world solutions. He is committed to cultivating collaboration across industry, academia, and regulation—believing that the next leap forward in health, wellness, and sustainable food systems will depend on integrated innovation.